Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02133209
Other study ID # NA_00091884
Secondary ID R01AT007176
Status Completed
Phase N/A
First received
Last updated
Start date May 2014
Est. completion date March 2018

Study information

Verified date August 2018
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

112 migraine subjects will be initially randomly assigned to Mindfulness-Based Stress Reduction (MBSR) or a Stress Management for Headache group (SMH). Outcomes, including headache frequency and impact and brain activity, will be assessed at baseline, prior to intervention, and at 3-, 6-, and 12-months.


Description:

Subjects in the MBSR group undergo a standardized 8-week MBSR course plus an additional 4 sessions over another 8 weeks that further emphasize and train subjects on MBSR concepts and skills. The SMH group will have 12 sessions spread out in a similar fashion to MBSR. Clinical outcomes are compared between groups at 3, 6, and 12 months to assess efficacy of MBSR. MRI scans are performed at baseline, 3 months, and 6 months changes in MRI metrics after MBSR and changes in MRI metrics associated with long-term MBSR practice. 30 healthy controls will also undergo MRI scanning to determine abnormal brain activity and structure in migraineurs compared to healthy controls across the 6 month period of observation.


Recruitment information / eligibility

Status Completed
Enrollment 98
Est. completion date March 2018
Est. primary completion date March 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria

- Are between 18 and 65 years of age

- Report between 4 and 14 headaches over 28 days

- Have a history of migraines lasting at least 1 year

- Are not currently using opioid ("narcotic") pain medication

Exclusion Criteria

- Are unable to undergo MRI

- Pregnant, lactating, or planning to become pregnant

- Current use of opioid medications

Inclusion Criteria for Healthy Volunteers (same exclusion criteria)

- Are between 18 and 65 years of age

- Free of any acute or chronic pain condition and reports no history of migraines

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness Based Stress Reduction
Mindfulness Based Stress Reduction (MBSR) involves focused attention while practicing moment-to-moment nonjudgmental awareness of the self with the goal of achieving emotional balance and clarity of thought. There will be 8 weekly sessions and a half day retreat followed by 4 bi-weekly sessions over a period of 4 months.
Stress Management for Headaches
Intervention involves a standardized stress management for headaches (SMH) group intervention that focuses on stress and general stress management skills, headache symptoms and their management, sleep hygiene, and healthy eating. There will be 8 weekly sessions followed by 4 bi-weekly sessions over a period of 4 months.

Locations

Country Name City State
United States Johns Hopkins University, Bayview Medical Campus Baltimore Maryland
United States University of Maryland School of Dentistry Baltimore Maryland

Sponsors (3)

Lead Sponsor Collaborator
Johns Hopkins University National Center for Complementary and Integrative Health (NCCIH), University of Maryland

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in headache frequency and impact Headache days per 28 days and headache-related disability (HIT-6) Baseline, 3, 6, and 12 months
Primary Change in gray matter volume Gray matter volume in the insula, dorsolateral prefrontal cortex, and cingulate Baseline, 3, and 6 months
Primary Change in Brain Function Overall activation of the dorsolateral prefrontal cortex and the task-positive cognitive network, and resting state connectivity to the insula Baseline, 3, and 6 months
Secondary Change in headache intensity Change in headache intensity Baseline, 3, 6, and 12 months
Secondary Change in Brain Structure Gray matter volume and white matter tracts across the whole brain Baseline, 3, and 6 months
Secondary Change in Whole Brain Function Cognitive-related activity, pain-related activity, and resting state across the whole brain Baseline, 3, and 6 months
See also
  Status Clinical Trial Phase
Completed NCT06192173 - Patent Foramen Ovale Closure in Migraine
Completed NCT05525611 - Cabergoline as a Preventive Treatment for Chronic Migraine N/A
Recruiting NCT03832998 - Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Phase 3
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Not yet recruiting NCT06428838 - Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context Phase 3
Completed NCT06304675 - Manageable Environmental Factors in Migraine
Completed NCT04084314 - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study Phase 4
Recruiting NCT05517200 - Pilot Study for a Machine Learning Test for Migraine
Completed NCT04179474 - Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine Phase 1
Recruiting NCT04603976 - Registry for Migraine - Clinical Core Phase 4
Completed NCT03597529 - CHOCOlate MeLatonin for AdolescenT MigrainE Phase 2
Completed NCT04197349 - Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman Phase 1
Recruiting NCT05891808 - miR-155 Expression in Episodic and Chronic Migraine
Active, not recruiting NCT05064371 - Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan Phase 3
Suspended NCT04069572 - Vibratory Stimulation for the Treatment of Chronic Pain N/A
Not yet recruiting NCT04859374 - Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach N/A
Not yet recruiting NCT03083860 - Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions. N/A
Completed NCT02905227 - A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder Phase 1
Enrolling by invitation NCT02532023 - The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients Phase 4
Completed NCT02108678 - One-Day Intervention for Depression and Impairment in Migraine Patients N/A